JACoW logo

Joint Accelerator Conferences Website

The Joint Accelerator Conferences Website (JACoW) is an international collaboration that publishes the proceedings of accelerator conferences held around the world.


https://doi.org/10.18429/JACoW-IPAC2019-THPMP033
Title Beam Characterisation Using MEDIPIX3 and EBT3 Film at the Clatterbridge Proton Therapy Beamline
Authors
  • J.S.L. Yap, J. Resta-López, R. Schnuerer, C.P. Welsch
    Cockcroft Institute, Warrington, Cheshire, United Kingdom
  • N.J.S. Balpresenter
    ASI, Amsterdam, The Netherlands
  • N.J.S. Balpresenter, M. Fransen, F. Linde
    NIKHEF, Amsterdam, The Netherlands
  • A. Kacperek
    The Douglas Cyclotron, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom
  • J.L. Parsons
    Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
  • J. Resta-López, R. Schnuerer, C.P. Welsch
    The University of Liverpool, Liverpool, United Kingdom
Abstract The Clatterbridge Cancer Centre (CCC) in the UK is a particle therapy facility providing treatment for ocular cancers using a 60 MeV passively scattered proton therapy beam. A model of the beamline using the Monte Carlo Simulation toolkit Geant4 has been developed for accurate characterisation of the beam. In order to validate the simulation, a study of the beam profiles along the delivery system is necessary. Beam profile measurements have been performed at multiple positions in the CCC beam line using both EBT3 GAFchromic film and Medipix3, a single quantum counting chip developed specifically for medical applications, typically used for x-ray detection. This is the first time its performance has been tested within a clinical, high proton flux environment. EBT3 is the current standard for conventional radiotherapy film dosimetry and was used to determine the dose and for correlation to fluence measured by Medipix3. The count rate linearity and doses recorded with Medipix3 were evaluated across the full range of available beam intensities, up to 3.12 x 10¹⁰ protons/s. The applicability of Medipix3 for proton therapy dosimetry is discussed and compared against the performance of EBT3.
Funding EU FP7 grant agreement 215080, H2020 Marie Skłodowska-Curie grant agreement No 675265 - Optimization of Medical Accelerators (OMA) project and the Cockcroft Institute core grant STGA00076-01.
Paper download THPMP033.PDF [1.887 MB / 4 pages]
Export download ※ BibTeX LaTeXText/WordRISEndNote
Conference IPAC2019
Series International Particle Accelerator Conference (10th)
Location Melbourne, Australia
Date 19-24 May 2019
Publisher JACoW Publishing, Geneva, Switzerland
Editorial Board Mark Boland (UoM, Saskatoon, SK, Canada); Hitoshi Tanaka (KEK, Tsukuba, Japan); David Button (ANSTO, Kirrawee, NSW, Australia); Rohan Dowd (ANSTO, Kirrawee, NSW, Australia); Volker RW Schaa (GSI, Darmstadt, Germany); Eugene Tan (ANSTO, Kirrawee, NSW, Australia)
Online ISBN 978-3-95450-208-0
Received 14 May 2019
Accepted 22 May 2019
Issue Date 21 June 2019
DOI doi:10.18429/JACoW-IPAC2019-THPMP033
Pages 3510-3513
Copyright
Creative Commons CC logoPublished by JACoW Publishing under the terms of the Creative Commons Attribution 3.0 International license. Any further distribution of this work must maintain attribution to the author(s), the published article's title, publisher, and DOI.